Step into this groundbreaking exploration of global psychedelic use with esteemed researcher Philippe Lucas, PhD. Conducted from May 19 to June 2, 2023, the survey revealed fascinating insights into the world of psychedelics. Psilocybin emerged as the most widely used psychedelic (75.3%), with "personal growth" (85.1%) and "general well-being" (68.7%) driving usage. Notably, 60% reported therapeutic use, offering valuable insights for public health, substance use, and policy development related to psychedelics.
00:00 Introduction
04:14 Presentation Starts
41:17 Q&A
Dr Philippe Lucas led this comprehensive survey, gathering responses from 6,379 participants and unveiling key trends in the naturalistic use of psychedelics. Don't miss this opportunity to delve into the rich tapestry of naturalistic psychedelic experiences around the globe. Dr Lucas will guide participants through the primary outcomes of the survey, providing a nuanced understanding of the impact on public health and psychedelic use.
Earn continuing education credits for this webinar at psychedelic.support/